These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
462 related items for PubMed ID: 17045636
21. Caffeine withdrawal syndrome in social interaction test in mice: effects of the NMDA receptor channel blockers, memantine and neramexane. Sukhotina IA, Zvartau EE, Danysz W, Bespalov AY. Behav Pharmacol; 2004 May; 15(3):207-14. PubMed ID: 15187578 [Abstract] [Full Text] [Related]
22. Effects of the uncompetitive NMDA receptor antagonist memantine on spatial memory in medial septal lesioned rats. Dashniani M, Burjanadze M, Beselia G, Chkhikvishvili N, Kruashvili L. Georgian Med News; 2011 Dec; (201):55-61. PubMed ID: 22306503 [Abstract] [Full Text] [Related]
23. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse. Parsons CG, Stöffler A, Danysz W. Neuropharmacology; 2007 Nov; 53(6):699-723. PubMed ID: 17904591 [Abstract] [Full Text] [Related]
24. Mechanism of action of memantine. Johnson JW, Kotermanski SE. Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266 [Abstract] [Full Text] [Related]
25. Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats. Camarasa J, Marimón JM, Rodrigo T, Escubedo E, Pubill D. Eur J Pharmacol; 2008 Jul 28; 589(1-3):132-9. PubMed ID: 18582864 [Abstract] [Full Text] [Related]
26. Okadaic acid (ICV) induced memory impairment in rats: a suitable experimental model to test anti-dementia activity. Kamat PK, Tota S, Saxena G, Shukla R, Nath C. Brain Res; 2010 Jan 14; 1309():66-74. PubMed ID: 19883632 [Abstract] [Full Text] [Related]
27. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine. Popik P, Danysz W. J Pharmacol Exp Ther; 1997 Feb 14; 280(2):854-65. PubMed ID: 9023300 [Abstract] [Full Text] [Related]
28. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Danysz W, Parsons CG. Int J Geriatr Psychiatry; 2003 Sep 14; 18(Suppl 1):S23-32. PubMed ID: 12973747 [Abstract] [Full Text] [Related]
29. MK-801 and memantine act differently on short-term memory tested with different time-intervals in the Morris water maze test. Duda W, Wesierska M, Ostaszewski P, Vales K, Nekovarova T, Stuchlik A. Behav Brain Res; 2016 Sep 15; 311():15-23. PubMed ID: 27180167 [Abstract] [Full Text] [Related]
30. Repeated treatment with N-methyl-d-aspartate antagonists in neonatal, but not adult, rats causes long-term deficits of radial-arm maze learning. Kawabe K, Iwasaki T, Ichitani Y. Brain Res; 2007 Sep 12; 1169():77-86. PubMed ID: 17706184 [Abstract] [Full Text] [Related]
31. Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration. Borre Y, Bosman E, Lemstra S, Westphal KG, Olivier B, Oosting RS. Neuropharmacology; 2012 Apr 12; 62(5-6):2010-7. PubMed ID: 22248638 [Abstract] [Full Text] [Related]
32. Memantine and recognition memory: possible facilitation of its behavioral effects by the nitric oxide (NO) donor molsidomine. Pitsikas N, Sakellaridis N. Eur J Pharmacol; 2007 Oct 01; 571(2-3):174-9. PubMed ID: 17628527 [Abstract] [Full Text] [Related]
33. Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression? Réus GZ, Stringari RB, Kirsch TR, Fries GR, Kapczinski F, Roesler R, Quevedo J. Brain Res Bull; 2010 Apr 05; 81(6):585-9. PubMed ID: 19954760 [Abstract] [Full Text] [Related]
34. The uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist memantine prolongs spatial memory in a rat delayed radial-arm maze memory task. Wise LE, Lichtman AH. Eur J Pharmacol; 2007 Dec 01; 575(1-3):98-102. PubMed ID: 17850786 [Abstract] [Full Text] [Related]
35. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia]. Tanović A, Alfaro V. Rev Neurol; 2007 Dec 01; 42(10):607-16. PubMed ID: 16703529 [Abstract] [Full Text] [Related]
36. D1 dopamine and NMDA receptors interactions in the medial prefrontal cortex: modulation of spatial working memory in rats. Rios Valentim SJ, Gontijo AV, Peres MD, Rodrigues LC, Nakamura-Palacios EM. Behav Brain Res; 2009 Dec 01; 204(1):124-8. PubMed ID: 19482047 [Abstract] [Full Text] [Related]
37. Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats. Mares P, Mikulecká A. Epilepsy Behav; 2009 Jan 01; 14(1):32-9. PubMed ID: 18786655 [Abstract] [Full Text] [Related]
38. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1). Manahan-Vaughan D, Wildförster V, Thomsen C. Eur J Neurosci; 2008 Oct 01; 28(7):1342-50. PubMed ID: 18973561 [Abstract] [Full Text] [Related]
39. The Alzheimer's disease drug memantine increases the number of radial glia-like progenitor cells in adult hippocampus. Namba T, Maekawa M, Yuasa S, Kohsaka S, Uchino S. Glia; 2009 Aug 01; 57(10):1082-90. PubMed ID: 19115386 [Abstract] [Full Text] [Related]
40. A specific role for group II metabotropic glutamate receptors in hippocampal long-term depression and spatial memory. Altinbilek B, Manahan-Vaughan D. Neuroscience; 2009 Jan 12; 158(1):149-58. PubMed ID: 18722513 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]